Crossmark

Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease

Crossref DOI link: https://doi.org/10.1038/s41409-020-01054-3

Published Online: 2020-09-15

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kharya, Gaurav http://orcid.org/0000-0003-2181-1825
Bakane, Atish

Agarwal, Shirali

Rauthan, Archana
License Information

Text and Data Mining valid from 2020-09-15

Version of Record valid from 2020-09-15
More Information

Article History

Received: 8 May 2020

Revised: 30 July 2020

Accepted: 2 September 2020

First Online: 15 September 2020

Compliance with ethical standards

:

: Center for Bone Marrow Transplant and Cellular Therapy, Indraprastha Apollo Hospital, New Delhi, India.

Document is current

Any future updates will be listed below